全球經皮貼片市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球經皮貼片市場預計將從2025年的70.7億美元成長至2034年的140.5億美元，2026年至2034年的複合年成長率（CAGR）為7.93%。隨著醫療專業人員尋求便捷易用的給藥方式，全球經皮貼劑市場穩定成長。經皮貼片透過皮膚將藥物直接輸送到血液中，從而實現劑量穩定，提高患者遵守用藥。這些貼片廣泛應用於疼痛管理、荷爾蒙療法、戒菸支持和其他治療領域。

多種因素共同推動了經皮貼片市場的擴張。慢性病盛行率的上升以及對非侵入性治療需求的成長，都促進了經皮給藥系統的應用。製藥公司正加大研發投入，致力於開發能提高藥物吸收率和療效的新型貼片配方。

隨著藥物傳輸技術的不斷進步，經皮吸收貼片市場前景光明。材料和貼片設計的創新有望實現更多種類藥物的傳遞。對便捷醫療保健解決方案和個人化療法的日益成長的需求預計將推動該市場的持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球經皮貼片市場：按類型分類

• 市場分析、洞察與預測
• 單層型（含藥黏合劑）
• 多層含藥黏合劑
• 矩陣
• 其他類型

第5章：全球經皮貼片市場：依應用領域分類

• 市場分析、洞察與預測
• 緩解疼痛
• 減少吸菸和戒菸支持
• 心血管疾病
• 神經病變
• 荷爾蒙療法
• 其他用途

第6章：全球經皮貼片市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第7章：全球經皮貼片市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AdhexPharma
  • Amneal Pharmaceuticals LLC
  • Cipla Ltd
  • CoriumInc
  • Gedeon Richter Plc
  • Henan Lingrui Pharmaceutical Co. Ltd
  • Hikma Pharmaceuticals PLC
  • Hisamitsu Pharmaceutical Co. Inc
  • Insud Pharma, SL（Agile Therapeutics）
  • Johnson & Johnson
  • Luye Pharma Group
  • Nitto Denko Corporation
  • Novartis AG
  • Purdue Pharma LP
  • Samyang Holdings Corporation（Samyang Biopharmaceuticals Corporation）
  • Teikoku Pharma USA Inc
  • Teva Pharmaceutical Industries Ltd
  • UCB SA
  • Viatris Inc
  • XPhyto Therapeutics Corp.（Vektor Pharma）

The global transdermal skin patches market size is expected to reach USD 14.05 Billion in 2034 from USD 7.07 Billion in 2025, growing at a CAGR of 7.93 during 2026-2034.The global transdermal skin patches market has grown steadily as healthcare providers seek convenient and controlled drug delivery methods. Transdermal patches deliver medication through the skin directly into the bloodstream, offering consistent dosing and improved patient compliance. These patches are widely used for pain management, hormone therapy, smoking cessation, and other medical treatments.

Several drivers are contributing to the expansion of the transdermal skin patches market. Increasing prevalence of chronic diseases and growing demand for non-invasive treatment options have encouraged the use of transdermal drug delivery systems. Pharmaceutical companies are investing in research to develop new patch formulations that improve drug absorption and therapeutic effectiveness.

Future prospects for the transdermal skin patches market appear promising as advancements in drug delivery technology continue. Innovations in materials and patch design may enable the delivery of a wider range of medications. Growing demand for convenient healthcare solutions and personalized treatment options is expected to support continued growth in this market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Single-Layer Drug-In-Adhesive
• Multi-Layer Drug-In-Adhesive
• Matrix
• Other Types

By Application

• Pain Relief
• Smoking Reduction And Cessation Aid
• Cardiovascular Disorders
• Neurological Disorders
• Hormonal Therapy
• Other Applications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• AdhexPharma, Amneal Pharmaceuticals LLC., Cipla Ltd., Corium, Inc., Gedeon Richter Plc., Henan Lingrui Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Hisamitsu Pharmaceutical Co. Inc., Insud Pharma, S.L. (Agile Therapeutics), Johnson & Johnson, Luye Pharma Group, Nitto Denko Corporation, Novartis AG, Purdue Pharma L.P., Samyang Holdings Corporation (Samyang Biopharmaceuticals Corporation), Teikoku Pharma USA Inc., Teva Pharmaceutical Industries Ltd., UCB S.A., Viatris Inc., XPhyto Therapeutics Corp. (Vektor Pharma)

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Single-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Multi-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Smoking Reduction And Cessation Aid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hormonal Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TRANSDERMAL SKIN PATCHES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 AdhexPharma
  • 9.2.2 Amneal Pharmaceuticals LLC
  • 9.2.3 Cipla Ltd
  • 9.2.4 CoriumInc
  • 9.2.5 Gedeon Richter Plc
  • 9.2.6 Henan Lingrui Pharmaceutical Co. Ltd
  • 9.2.7 Hikma Pharmaceuticals PLC
  • 9.2.8 Hisamitsu Pharmaceutical Co. Inc
  • 9.2.9 Insud Pharma, S.L. (Agile Therapeutics)
  • 9.2.10 Johnson & Johnson
  • 9.2.11 Luye Pharma Group
  • 9.2.12 Nitto Denko Corporation
  • 9.2.13 Novartis AG
  • 9.2.14 Purdue Pharma L.P
  • 9.2.15 Samyang Holdings Corporation (Samyang Biopharmaceuticals Corporation)
  • 9.2.16 Teikoku Pharma USA Inc
  • 9.2.17 Teva Pharmaceutical Industries Ltd
  • 9.2.18 UCB S.A
  • 9.2.19 Viatris Inc
  • 9.2.20 XPhyto Therapeutics Corp. (Vektor Pharma)